HYPERHEP B
Google image searchProduct monograph
Active ingredient
hepatitis b immunoglobulin (human), 110 UNIT/0.5 ML
DIN: 02520125
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: PREFILLED SYRINGE (NEONATAL)
Schedule: Schedule D
Company: GRIFOLS THERAPEUTICS LLC
Date: 16-AUG-2022
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BB — Specific immunoglobulins (ATC, ATC/DDD)
- J06BB04 — HEPATITIS B IMMUNOGLOBULIN (ATC/DDD)
Reference brand drug: Hepagam B, Hyperhep B
Pharmaceutical standard: MFR
